US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 1.069
- -0.151-12.38%
Close Nov 14 16:00 ET
- 1.110
- +0.041+3.84%
Pre 08:00 ET
76.22MMarket Cap-4647P/E (TTM)
1.190High1.060Low85.53KVolume1.180Open1.220Pre Close95.65KTurnover1.63%Turnover RatioLossP/E (Static)71.30MShares49.00052wk High1.58P/B5.62MFloat Cap0.92552wk Low--Dividend TTM5.25MShs Float49.000Historical High--Div YieldTTM10.66%Amplitude0.925Historical Low1.118Avg Price1Lot Size
Citius Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|
| Operating Cash Flow (Indirect Method) | ||
| Cash flow from continuing operating activities | 0 | 0 |
| Net income from continuing operations | -133.72%-12.7M | ---5.43M |
| Deferred tax | 0.00%576K | --576K |
| Change In working capital | 109.11%10.16M | --4.86M |
| -Change in prepaid assets | -409.47%-5.04M | ---990.18K |
| -Change in payables and accrued expense | 159.98%15.2M | --5.85M |
| Cash from discontinued investing activities | ||
| Operating cash flow | --0 | --0 |
| Investing cash flow | ||
| Cash flow from continuing investing activities | ||
| Cash from discontinued investing activities | ||
| Financing cash flow | ||
| Cash flow from continuing financing activities | ||
| Cash from discontinued financing activities | ||
| Net cash flow | ||
| Beginning cash position | --0 | --0 |
| End cash Position | --0 | --0 |
| Free cash flow | --0 | --0 |
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data